CORRECTING and REPLACING Pure H2O Bio-Technologies, Inc., Announces Release of a New Informational Video

  
    
  
  
    
      Please replace the release dated Nov. 4, 2008 with the following 
      corrected version due to multiple revisions.
    
    
      The corrected release reads:
    
    
      PURE H2O BIO-TECHNOLOGIES, 
      INC., ANNOUNCES RELEASE OF A NEW INFORMATIONAL VIDEO
    
    
      Pure H2O Bio-Technologies, Inc. (Pink 
      Sheets:PRHB) announced today the release of its new informational video 
      and transcript detailing the Company’s 
      Silver-TTOTM (tetrasilver tetraoxide) 
      technology. The PRHB Silver-TTOTM technology can 
      now be viewed as very competitive and a significant improvement over all 
      current water treatment products from a business development perspective.
    
    
      The video can be viewed on the Company’s 
      web-site at www.pureh20biotech.com. 
      You can also visit our video at www.jerryvconsulting.com. 
      Additional sites will be forthcoming.
    
    
      Silver-TTO™ Water Disinfection of Resistant Cryptosporidium
    
    
      Market Opportunity – Treatment of Emerging 
      Water-Borne Disease Pathogens
    
    
      Over the past 20-years, increasing demands for pure drinking water by 
      hospitals, clinics, nursing homes, residential consumers as well as 
      recreational, educational, military, and commercial facilities have 
      generated the need for water treatment technology that can disinfect 
      organisms that are refractory to conventional water treatment and 
      filtration. 286 million people in the US receive their water from public 
      drinking water systems. In 2007, the EPA determined that over 51,252 or 
      32.9% of the drinking water systems in the US reported at least one 
      health-based standard, monitoring and reporting, or other violation. 
      Moreover, there is an additional need for the 5,747 registered hospitals 
      in the US to provide safe drinking water in the heath care delivery 
      setting. International opportunities are also another market sector 
      particularly in developing countries. Pure H20 
      Bio-Technologies, Inc., intends to leverage its novel Silver TTO™ 
      disinfection technology to produce water treatment systems that 
      effectively treat chlorine-resistant water-borne pathogens such as 
      Cryptosporidium and related enteric bacteria. The proprietary 
      Silver TTO™ technology has the potential to 
      disrupt the existing water treatment market in commercial, institutional 
      as well as residential market sectors.
    
    
      PRHB is currently working with several marketing firms to assist the 
      Company in its effort to provide additional exposure regarding its 
      Silver-TTOTM technology to a broader market 
      including, but not limited to, the medical industry. "We believe this 
      video effectively represents that our Silver TTOTM 
      disinfectant is far superior over the current technologies", stated 
      Joseph Doxey, CEO of Pure H20 Bio-Technologies, 
      Inc.
    
    
      About Pure H20 Bio-Technologies, Inc.:
    
    
      Pure H20 Bio-Technologies, Inc. (PRHB) is a 
      publicly held company specializing in the manufacturing, design, and 
      sale of its unique residential, commercial and hospital point-of-use 
      potable water disinfection systems. These systems are specifically 
      designed to work effectively against water-borne pathogens and remove 
      heavy metals and objectionable biomasses.
    
    
      The foregoing press release contains forward-looking statements that can 
      be identified by such terminology as "expects," "potential,""suggests," 
      "may," "intends," or similar expressions. Such forward-looking 
      statements involve known and unknown risks, uncertainties, and other 
      factors that may cause the actual results to be materially different 
      from any future results, performance or achievements expressed or 
      implied by such statements. In particular, management's expectations 
      regarding future research, development, and/or commercial results could 
      be affected by, among other things, uncertainties relating to the 
      availability of future financing; unexpected regulatory delays or 
      government regulation generally; the company's ability to obtain or 
      maintain patent and other proprietary intellectual property protection; 
      and completion in general. Forward-looking statements speak only as to 
      the date they were made. The company does not undertake to update 
      forward-looking statements to reflect circumstances or events that occur 
      after the date the forward-looking statements are made.